About this trial
In humans, insulin is secreted in pulses from the pancreatic beta-cells, and these oscillations help to maintain fasting plasma glucose levels within a narrow normal range. Given the fluctuations in insulin concentrations, oscillations enhance precision of control. The hyperinsulinemic euglycemic clamp test (clamp) involves a continuous infusion of insulin and is the gold standard for measuring insulin sensitivity. In this study, insulin sensitivity measured using the standard clamp will be compared with a clamp in which the same total amount of insulin as the standard clamp is infused every five minutes instead of continuously.
Eligibility criteria
Qualifiers
Completion of the Motivate Study (NCT05649176)
Disqualifiers
Non-completion of the end-of-study hyperinsulinemic euglycemic clamp test of the Motivate study
Trial design
Treatments tested in this trial
- Continuous Insulin administration during hyperinsulinemic euglycemic clamp test
- Pulsatile Insulin administration during hyperinsulinemic euglycemic clamp test
Treatment groups
Locations
1Sponsors and collaborators
Pennington Biomedical Research Center
Lead sponsor